Allergan Target Faces Bid To Halt Vote On $30M Merger
Reproductive disorder drugmaker Repros Therapeutics Inc. has been hit with a stockholder suit in Delaware federal court that seeks to block a proposed $30 million acquisition by Allergan PLC unless Repros...To view the full article, register now.
Already a subscriber? Click here to view full article